- January 5, 2017
Knopp Biosciences Receives Key Patent Directed to Treatment for Hypereosinophilic Syndromes, Asthma, and Other Eosinophilic Diseases
Knopp Biosciences LLC announced it received U.S. Patent No. 9,468,630 entitled...Read more »
- December 14, 2016
Knopp Biosciences Reported Steroid-sparing Effects of Dexpramipexole in HES at American Society of Hematology 2016 Annual Meeting
Knopp Biosciences LLC today announced the presentation of data from an ongoing,...Read more »
Omaze is a crowd funding platform that allows charities to leverage the tremendous reach of social influencers to raise money for their causes.